CDK4/6 Inhibitor Resistant Breast Cancer Models
Leverage our extensive panel of CDK4/6 inhibitor resistant breast cancer models, including: In vitro induced Palbociclib resistant MCF-7 cell line...
Continue ReadingKnowledge Library
Ligand Finding and Chemistry Workflows for Targeted Protein Degradation
This webinar will focus on aspects related to PROTAC discovery and chemistry workflows, such as ligand finding strategies, synthesis optimization,...
Continue Reading Biological Characterization and Development Workflows for Targeted Protein Degradation
This webinar will focus on PROTAC biology workflows, such as in vitro screening assays, in vivo testing, and optimization of...
Continue Reading
How Does It Work? | Peptide-Oligonucleotide Conjugates
This week’s episode of our “How Does It Work?” series features Peptide-Oligonucleotide Conjugates. Peptide-oligonucleotide conjugates are made up of peptide...
Continue Reading How Does It Work? | Aptamers
Nucleic acids have long been regarded as biological compounds for storing and transferring information. However, their functionalities are far more...
Continue Reading How Does It Work? | Individualized Oligonucleotide Therapies
In this week’s episode of our “How Does It Work?” video series, we explore Individualized Oligonucleotide Therapies. Around 6 billion...
Continue Reading How Does It Work? | Antibody Drug Conjugates
In this week’s installment of our “How Does It Work?” video series, we explore Antibody Drug Conjugates. Monoclonal antibodies are...
Continue Reading